Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers Now Available - Sandler Research

DALLAS, December 1, 2010 /PRNewswire/ -- Sandler Research announces it will carry Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers Research Report in its store.

Browse the complete Report on: http://www.sandlerresearch.org/reports/41367-pharmaceutical-analytical-servic es-outsourcing-in-india-cost-sav.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

    Browse All GBI Research Reports at
http://www.sandlerresearch.org/publishers/gbi-research/

GBI Research's medical devices report, "Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers" provides key data, information and analysis on the pharmaceutical analytical services outsourcing in india. The report provides market landscape, competitive landscape and market trends information on the segments within the analytical services market. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, services technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

    Scope

    - Key geographies covered is India
    - Market size and company share data the segments with
      pharmaceutical anlaytical laboratories market
    - Annualized market revenues data from 2002 to 2009, forecast
      forward for 7 years to 2016. Company shares data for 2009.
    - Qualitative analysis of key market trends, market drivers, and
      restraints by each category within the pharmaceutical analytical
      services market.
    - The report also covers information on the leading market players,
      the competitive landscape, services and technologies.


    Reasons to buy

    - Develop business strategies by understanding the trends and
      developments that are driving the Indian pharmaceutical analytical
      services market.
    - Design and develop your product development, marketing and sales
      strategies.
    - Exploit M&A opportunities by identifying market players with the
      promising products
    - Develop market-entry and market expansion strategies.
    - Identify key players best positioned to take advantage of the
      emerging market opportunities.
    - Exploit in-licensing and out-licensing opportunities by
      identifying products, most likely to ensure a robust return.
    - What's the next being thing in the pharmaceutical analytical
      services market? - Identify, understand and capitalize.
    - Make more informed business decisions from the insightful and
      in-depth analysis of the Indian pharmaceutical analytical services
      market and the factors shaping it.


    Browse All Latest Reports:
http://www.sandlerresearch.org/LatestReport.aspx

Browse All Tags : http://www.sandlerresearch.org/tagIndex.aspx

About Us

Sandler Research comprises an online library of 20,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004


    http://www.sandlerresearch.org/
    http://sandlerresearch.blogspot.com/

SOURCE MarketsandMarkets